National Cancer Institute; Amended Notice of Meeting, 46647 [07-4068]

Download as PDF Federal Register / Vol. 72, No. 161 / Tuesday, August 21, 2007 / Notices DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Cancer Institute; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Cancer Institute Initial Review Group, Subcommittee J—Population and Patient-Oriented Training. Date: October 29–30, 2007. Time: 8 a.m. to 4 p.m. Agenda: To review and evaluate grant applications. Place: The Westin Arlington Gateway, 801 North Glebe Road, Arlington, VA 22203. Contact Person: Ilda M. McKenna, PhD., Scientific Review Administrator, Research Training Review Branch, Division of Extramural Activities, National Cancer Institute, 6116 Executive Boulevard, Room 8111, Bethesda, MD 20892, 301–496–7481, mckennai@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS) Dated: August 13, 2007. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. 07–4067 Filed 8–20–07; 8:45 am] BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES rmajette on PROD1PC64 with NOTICES National Institutes of Health National Cancer Institute; Amended Notice of Meeting Notice is hereby given of a change in the meeting of the National Cancer Institute Special Emphasis Panel, September 26, 2007, 8 a.m. to VerDate Aug<31>2005 15:08 Aug 20, 2007 Jkt 211001 September 27, 2007, 5 p.m., Bethesda Marriott, 5151 Pooks Hill Road, Bethesda, MD, 20814 which was published in the Federal Register on July 31, 2007, 72 FR 41760. The meeting notice is amended to reflect the change in the name of the committee from ‘‘SPORE in Lymphoma, Prostate, Breast & Skin Cancers’’ to ‘‘SPORE in Lymphoma, Prostate, Breast, Skin, Leukemia & GI Cancers’’. The meeting is closed to the public. Dated: August 13, 2007. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. 07–4068 Filed 8–20–07; 8:45 am] BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Cancer Institute; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Cancer Institute Initial Review Group, Subcommittee G—Education. Date: September 11–12, 2007. Time: 8 a.m. to 4:45 p.m. Agenda: To review and evaluate grant applications. Place: Gaithersburg Marriott Washingtonian Center, 204 Boardwalk Place, Gaithersburg, MD 20878. Contact Person: Sonya Roberson, PhD., Scientific Review Administrator, Resources and Training Review Branch, Division of Extramural Activities, National Cancer Institute, 6116 Executive Blvd., Room 8109, Bethesda, MD 20892, 301–594–1182, robersos@mail.nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel, R25 Special Emphasis Panel (SEP). Date: September 11, 2007. Time: 5 p.m. to 7 p.m. Agenda: To review and evaluate grant applications. PO 00000 Frm 00049 Fmt 4703 Sfmt 4703 46647 Place: Gaithersburg Marriott Washingtonian Center, 204 Boardwalk Place, Gaithersburg, MD 20878. Contact Person: Jeannette F. Korczak, PhD., Scientific Review Administrator, Resources and Training Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 6116 Executive Blvd., Room 8115, Bethesda, MD 20892, 301–496–9767, korczakj@mail.nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel, Oral Bioavailability Enhancement. Date: September 18, 2007. Time: 2 p.m. to 4 p.m. Agenda: To review and evaluate contract proposals. Place: National Institutes of Health, 6130 Executive Blvd., Conference Room C, Rockville, MD 20852. (Telephone Conference Call). Contact Person: Thomas M. Vollberg, PhD., Scientific Review Administrator, Special Review And Logistics Branch, Division of Extramural Activities, National Cancer Institute, 6116 Executive Blvd., Room 7142, Bethesda, MD 20892, 301–594–9582, vollbert@mail.nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel, Clinical Studies SEP. Date: October 3–4, 2007. Time: 8 a.m. to 1 p.m. Agenda: To review and evaluate grant applications. Place: Bethesda Marriott, 5151 Pooks Hill Road, Bethesda, MD 20814. Contact Person: Majed M. Hamawy, PhD., MBA, Scientific Review Administrator, Research Programs Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 6116 Executive Boulevard, Room 8135, Bethesda, MD 20852, 301–496– 7565, mh101v@nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel, Clinical SEP 2. Date: October 4, 2007. Time: 1 p.m. to 2 p.m. Agenda: To review and evaluate grant applications. Place: Bethesda Marriott, 5151 Pooks Hill Road, Bethesda, MD 20814. Contact Person: Peter J. Wirth, PhD., Scientific Review Administrator, Research Programs Review Branch, Division of Extramural Activities, National Cancer Institute, 6116 Executive Boulevard, Room 8131, Bethesda, MD 20892–8328, 301–496– 7565, pw2q@nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS). E:\FR\FM\21AUN1.SGM 21AUN1

Agencies

[Federal Register Volume 72, Number 161 (Tuesday, August 21, 2007)]
[Notices]
[Page 46647]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 07-4068]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Amended Notice of Meeting

    Notice is hereby given of a change in the meeting of the National 
Cancer Institute Special Emphasis Panel, September 26, 2007, 8 a.m. to 
September 27, 2007, 5 p.m., Bethesda Marriott, 5151 Pooks Hill Road, 
Bethesda, MD, 20814 which was published in the Federal Register on July 
31, 2007, 72 FR 41760.
    The meeting notice is amended to reflect the change in the name of 
the committee from ``SPORE in Lymphoma, Prostate, Breast & Skin 
Cancers'' to ``SPORE in Lymphoma, Prostate, Breast, Skin, Leukemia & GI 
Cancers''. The meeting is closed to the public.

    Dated: August 13, 2007.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 07-4068 Filed 8-20-07; 8:45 am]
BILLING CODE 4140-01-M

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.